398 related articles for article (PubMed ID: 15707726)
21. Physical-chemical characterization of binary and ternary systems of ketoprofen with cyclodextrins and phospholipids.
Cirri M; Maestrelli F; Mennini N; Mura P
J Pharm Biomed Anal; 2009 Dec; 50(5):683-9. PubMed ID: 19095391
[TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
23. Availability of phenindione-beta-cyclodextrin inclusion complex.
Tous SS; el-Sayed AM; el-Harras SA; Jun HW
Pharmazie; 1992 May; 47(5):365-8. PubMed ID: 1409827
[TBL] [Abstract][Full Text] [Related]
24. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
Liu J; Qiu L; Gao J; Jin Y
Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
[TBL] [Abstract][Full Text] [Related]
25. Lyophilization monophase solution technique for improvement of the physicochemical properties of an anticancer drug, flutamide.
Elgindy N; Elkhodairy K; Molokhia A; Elzoghby A
Eur J Pharm Biopharm; 2010 Feb; 74(2):397-405. PubMed ID: 19944160
[TBL] [Abstract][Full Text] [Related]
26. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.
Shinde VR; Shelake MR; Shetty SS; Chavan-Patil AB; Pore YV; Late SG
J Pharm Pharmacol; 2008 Sep; 60(9):1121-9. PubMed ID: 18718114
[TBL] [Abstract][Full Text] [Related]
27. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies.
Ventura CA; Giannone I; Musumeci T; Pignatello R; Ragni L; Landolfi C; Milanese C; Paolino D; Puglisi G
Eur J Med Chem; 2006 Feb; 41(2):233-40. PubMed ID: 16387393
[TBL] [Abstract][Full Text] [Related]
28. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
Sbârcea L; Udrescu L; Drăgan L; Trandafirescu C; Szabadai Z; Bojiţă M
Pharmazie; 2011 Aug; 66(8):584-9. PubMed ID: 21901980
[TBL] [Abstract][Full Text] [Related]
29. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
30. The novel application of tertiary butyl alcohol in the preparation of hydrophobic drug-HPbetaCD complex.
Wang Z; Deng Y; Zhang X
J Pharm Pharmacol; 2006 Mar; 58(3):409-14. PubMed ID: 16536910
[TBL] [Abstract][Full Text] [Related]
31. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.
Rawat S; Jain SK
Eur J Pharm Biopharm; 2004 Mar; 57(2):263-7. PubMed ID: 15018983
[TBL] [Abstract][Full Text] [Related]
32. Physical-chemical characterization of binary systems of metformin hydrochloride with triacetyl-beta-cyclodextrin.
Corti G; Capasso G; Maestrelli F; Cirri M; Mura P
J Pharm Biomed Anal; 2007 Nov; 45(3):480-6. PubMed ID: 17822867
[TBL] [Abstract][Full Text] [Related]
33. Preparation, characterization and dissolution enhancement of mefloquine hydrochloride-betaCD inclusion complex.
Patil SS; Patil AL
Pharmazie; 2011 Jun; 66(6):416-20. PubMed ID: 21699079
[TBL] [Abstract][Full Text] [Related]
34. Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement.
Semcheddine F; Guissi Nel I; Liu X; Wu Z; Wang B
AAPS PharmSciTech; 2015 Jun; 16(3):704-15. PubMed ID: 25511809
[TBL] [Abstract][Full Text] [Related]
35. Improvement of physical stability and dissolution rate of celecoxib suspensions by complexation with beta-cyclodextrins.
Chandra Sekhara Rao G; Satish Kumar M; Mathivanan N; Bhanoji Rao ME
Pharmazie; 2004 Aug; 59(8):627-30. PubMed ID: 15378853
[TBL] [Abstract][Full Text] [Related]
36. Enhancement in dissolution pattern of piribedil by molecular encapsulation with beta-cyclodextrin.
Demirel M; Buyukkoroglu G; Kalava BS; Yazan Y
Methods Find Exp Clin Pharmacol; 2006 Mar; 28(2):83-8. PubMed ID: 16636717
[TBL] [Abstract][Full Text] [Related]
37. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
Ruan LP; Yu BY; Fu GM; Zhu DN
J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
[TBL] [Abstract][Full Text] [Related]
38. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
Jadhav GS; Vavia PR
Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
[TBL] [Abstract][Full Text] [Related]
39. Solubility and stability enhancement of atorvastatin by cyclodextrin complexation.
Palem CR; Patel S; Pokharkar VB
PDA J Pharm Sci Technol; 2009; 63(3):217-25. PubMed ID: 20069794
[TBL] [Abstract][Full Text] [Related]
40. Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary systems.
Veiga F; Fernandes C; Maincent P
Drug Dev Ind Pharm; 2001 Jul; 27(6):523-32. PubMed ID: 11548859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]